products of the Plaintiff sold under the brand "ULTRAMOL" are
paracetamol preparations in different dosage forms. The grievance of the
Plaintiff ... ULTRAMOL" in different dosage forms of the
same medicine, i.e., paracetamol.
CS(COMM) 240/2022 Page 1 of 19
Signature Not Verified
Digitally
stated to have adopted the trademark
'ULTRAMOL' in respect of paracetamol preparations, in several variants, in
CS(COMM) 240/2022 Page ... Defendant No.1 in identical manner for identical
pharmaceutical preparations i.e, paracetamol, deserves to be protected as the
Plaintiff is the prior user
case relates to the
pharmaceutical preparation containing 'ibuprufen' and 'paracetamol'. The
Plaintiff claims rights in the mark 'COMBIFLAM', which ... plaintiff launched its
product COMBIFLAM PLUS tablets, a formulation of
paracetamol and caffeine. In 2014, the plaintiff applied
for registration of 'COMBIFLAM
deliberately adopted an identical mark 'NISE-
P' for similar paracetamol preparations i.e. analgesic and antipyretic
suspension to cause confusion among members ... mark 'NISE' whereas the Defendant is selling
Aceclofenac & Paracetamol Suspension. An identical mark is being used for
different combinations and different content
Preparations
and Substances. The Plaintiff manufactures and markets tablets containing
Aceclofenac and Paracetamol under the trademark 'ALDIGESIC P', in a
distinctive trade dress ... Defendants, who manufacture and market their
product containing Aceclofenac and Paracetamol, under the mark
'ALGESIC P', in 5x3 blister packs of peach colour
